ATPIII
Showing 1 - 25 of 46
Rheumatoid Arthritis Trial in Durham (SWET: Supervised Weight loss and Exercise Training, CHAT: Counseling Health As Treatment)
Active, not recruiting
- Rheumatoid Arthritis
- SWET: Supervised Weight loss and Exercise Training
- CHAT: Counseling Health As Treatment
-
Durham, North CarolinaDuke Center for Living
Nov 30, 2022
Hypercholesterolemia Trial in United States (ETC-1002, Placebo)
Bipolar Disorder Trial in United States (Metformin, healthy lifestyle intervention (LIFE))
Active, not recruiting
- Bipolar Disorder
- Metformin
- healthy lifestyle intervention (LIFE)
-
Covington, Kentucky
- +28 more
Feb 25, 2022
Metabolic Syndrome Trial in Mexico City (ATP III dietary intervention)
Active, not recruiting
- Metabolic Syndrome
- ATP III dietary intervention
-
Mexico City, MexicoInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
Aug 8, 2022
Stroke Card Long-term Follow-Up
Enrolling by invitation
- Ischemic Stroke
- TIA
-
Innsbruck, Tyrol, Austria
- +1 more
Aug 31, 2021
Diabetes, Diabetes, Type 2, PreDiabetes Trial in Baltimore (The Diabetes Prevention Program)
Enrolling by invitation
- Diabetes Mellitus
- +9 more
- The Diabetes Prevention Program
-
Baltimore, MarylandJohns Hopkins School of Nursing
Dec 9, 2021
Cryptogenic Sensory Peripheral Neuropathy in Metabolic Syndrome Trial in United States (topiramate, Placebo)
Completed
- Cryptogenic Sensory Peripheral Neuropathy in Metabolic Syndrome
- topiramate
- Placebo
-
Birmingham, Alabama
- +19 more
Mar 29, 2022
Cardiometabolic Syndrome Trial in Malang (ß-1,3/1,6-D-Glucan From Mycelia Extract of Indonesia's Ganoderma Lucidum Group,
Enrolling by invitation
- Cardiometabolic Syndrome
- β-1,3/1,6-D-Glucan From Mycelia Extract of Indonesia's Ganoderma Lucidum Group
- Placebo Group
-
Malang, East Java, IndonesiaGeneral Hospital of Brawijaya University (Rumah Sakit Universita
Oct 3, 2021
Metabolic Syndrome Trial in Santiago (Low fat diet, Mediterranean diet, Mediterranean diet plus psychological well-being
Enrolling by invitation
- Metabolic Syndrome
- Low fat diet
- +2 more
-
Santiago, Metropolitana, ChilePontificia Universidad Católica de Chile
Aug 3, 2022
Obesity Trial (High-intensity Interval Training, Moderate-intensity continuous training)
Not yet recruiting
- Obesity
- High-intensity Interval Training
- Moderate-intensity continuous training
- (no location specified)
Jan 25, 2023
Cardiovascular Risk Factor, Diabetes, Type 2 Trial in Chertsey (TOBACCO CIGARETTES, COMBUSTION-FREE NICOTINE DELIVERY SYSTEMS
Recruiting
- Cardiovascular Risk Factor
- Diabetes Mellitus, Type 2
- TOBACCO CIGARETTES
- COMBUSTION-FREE NICOTINE DELIVERY SYSTEMS (C-F NDS)
-
Chertsey, Surrey, United KingdomAshford and St Peters NHS Foundation Trust
Oct 26, 2022
Inflammation, Lower Urinary Tract Symptoms Trial in Worldwide
Recruiting
- Inflammation
- Lower Urinary Tract Symptoms
-
Nicosia, Cyprus
- +6 more
Apr 22, 2021
Metabolic Syndrome, Testicular Cancer, Leydig Cell Failure in Adult Trial in Copenhagen (Testosterone, Placebos)
Completed
- Metabolic Syndrome
- +2 more
- Testosterone
- Placebos
-
Copenhagen, DenmarkRigshospitalet
Mar 5, 2020
Incidence of Type 2 Diabetes in the di@Bet.es Study
Completed
- Diabetes Mellitus, Type 2
-
Málaga, Malaga, SpainHospital Regional Universitario
Nov 29, 2019
Obesity, Abdominal, Hypertension, Quality of Life Trial in Quito (: Nursing intervention in two risk factors of the Metabolic
Completed
- Obesity, Abdominal
- +3 more
- : Nursing intervention in two risk factors of the Metabolic Syndrome, abdominal obesity and arterial hypertension and quality of life in the climacteric period.
-
Quito, Pichincha, EcuadorCentro de Salud de San Antonio de Pichincha
May 23, 2022
Metabolic Syndrome, Obesity Trial (genistein, Placebo)
Completed
- Metabolic Syndrome
- Obesity
- genistein
- Placebo
- (no location specified)
Sep 24, 2019
Hyperlipidemia, Hypercholesterolemia, Cardiovascular Disease Trial in United States
Completed
- Hyperlipidemia
- +16 more
-
Little Rock, Arkansas
- +13 more
Feb 27, 2020
Schizophrenia and Disorders With Psychotic Features Trial in Canada (Ziprasidone HCL (oral))
Terminated
- Schizophrenia and Disorders With Psychotic Features
- Ziprasidone HCL (oral)
-
Calgary, Alberta, Canada
- +31 more
Mar 2, 2021
Metabolic Syndrome Trial (Orange Juice (500 mL/d))
Completed
- Metabolic Syndrome
- Orange Juice (500 mL/d)
- (no location specified)
Apr 2, 2019
Breast Tumors, Endothelial Dysfunction, Cardiovascular Disease Trial in Aarhus (Venous occlusion plethysmography, SphygmoCor,
Completed
- Breast Neoplasms
- +3 more
- Venous occlusion plethysmography
- +4 more
-
Aarhus, Jutland, DenmarkAarhus University Hospital
Oct 8, 2019
Stroke, Ischemic Attack, Transient, Secondary Prevention Trial in Innsbruck (Active Comparator: Extended Standard Care (Stroke
Completed
- Stroke
- +4 more
- Active Comparator: Extended Standard Care (Stroke Card)
- Active Comparator: Standard Care
-
Innsbruck, Tyrol, AustriaDepartment of Neurology, Medical University Innsbruck
Apr 5, 2019
Rheumatoid Arthritis Trial in Alexandria, Banha, Cairo (tocilizumab [RoActemra/Actemra], Methotrexate)
Completed
- Rheumatoid Arthritis
- tocilizumab [RoActemra/Actemra]
- Methotrexate
-
Alexandria, Egypt
- +8 more
Jul 17, 2017
Atherosclerosis in Atrial Fibrillation
Unknown status
- Atrial Fibrillation
- +4 more
-
Rome, ItalyUmberto I Policlinico di Roma, Sapienza Università di Roma
Feb 20, 2018
HIV Infection, Cardiovascular Disease Risk Trial in Minneapolis (Pravastatin, Lisinopril)
Completed
- HIV Infection
- Cardiovascular Disease Risk
-
Minneapolis, MinnesotaHennepin County Medical Center
Oct 19, 2017
Cardiovascular Diseases, Hypercholesterolemia, Hypertension Trial (Palm-Pilot Intervention)
Completed
- Cardiovascular Diseases
- +2 more
- Palm-Pilot Intervention
- (no location specified)
Nov 4, 2016